You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com
the US Food and Drug Administration (FDA) approved PEGASYS for
the treatment of chronic hepatitis B. Already the most prescribed
hepatitis C medication in the United States, PEGASYS is the
first and only pegylated interferon
approved for the treatment of chronic hepatitis B, including
both main types of the virus.
helps in two important ways:
slows replication of the hepatitis B virus.
- PEGASYS boosts the body's immune system.